Pathogenesis of the antiphospholipid syndrome;Physiopathologie du syndrome des antiphospholipides

Presse Medicale

Volumn 36, Issue 4 II, 2007, Pages 667-673

  Pasquali, Jean Louis ^a   Poindron, Vincent ^a   Korganow, Anne Sophie ^a   Martin, Thierry ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; HEPARIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTHROMBIN ANTIBODY; THROMBOMODULIN; VITRONECTIN; AUTOANTIBODY;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURFACE; FETUS RESORPTION; FUNCTION TEST; HUMAN; LEUKOCYTE ACTIVATION; NONHUMAN; ORGANOGENESIS; PATHOGENESIS; PHAGOCYTE; SHORT SURVEY; SOMATIC MUTATION; ANIMAL; BLOOD; FEMALE; IMMUNOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 34047126386     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2006.11.013     Document Type: Short Survey

References (30)

1. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Thromb Haemost 4 (2005) 295-306
2. Galli M., Luciani D., Bertolini G., and Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome : a systematic review of the literature. Blood 101 (2003) 1827-1832
3. Galli M., and Barbui T. Antiphospholipid antibodies and pregnancy. Best Pract Res Clin Haematol. 16 (2003) 211-225
4. Giles I.P., Isenberg D.A., Latchman D.S., and Rahman A. How to do antiphospholipid antibodies bind β2-glycoprotein I?. Arthritis Rheum 48 (2003) 2111-2121
5. Tinahones F.J., Cuadrado M.J., Khamashta M.A., Mujic F., Gomez-Zumaquero J.M., Collantes E., et al. Lack of cross-reaction between antibodies to β2-glycoprotein I and oxidised low-density lipoprotein in patients with antiphospholipid syndrome. Br J Rheumatol 37 (1998) 746-749
6. Ames P.R.J. Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus : a unifying "membrane stress syndrome" hypothesis. Lupus 3 (1994) 371-377
7. Hayawaka K., and Hardy R.R. Development and function of B1 cells. Curr Opin Immunol 12 (2000) 346-353
8. Lutters B.C.H., Derksen R.H.W.M., Tekelenburg W.L., Lenting P.J., Amout J., and de Grott P.G. Dimers of β2-glycoprotein I increase patelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem 278 (2003) 33831-33838
9. Atsumi T., Ieko M., Bertolaccini M.L., Ichikawa K., Tsutsumi A., Matsuura E., et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 43 (2000) 1982-1993
10. Oosting J.D., Derksen R.H., Bobbink I.W., Hacken T.M., Bouma B.N., and de Grott P.G. Antiphospholipid antibodies directed against a combination of phospholipids with prothombin, protein C, or protein S. An explanation for their pathogenic mechanism?. Blood 81 (1993) 2618-2625
11. Smirnov M.D., Triplett D.T., Comp P.C., Esmon N.L., and Esmon C.T. On the role of phosphtidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 95 (1995) 309-316
12. Comp P.C., DeBault L.E., Esmon N.L., and Esmon C.T. Human thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants. Blood 62 (1983) 299a
13. Freyssinet J.M., Wiesel M.L., Gauchy J., Boneu B., and Cazenave J.P. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity. A mechanism for thrombosis. Thromb Haemost 55 (1986) 309-313
14. Rand J.H., Wu X.X., Quinn A.S., Chen P.P., Mc Crae K.R., Bovill E.G., et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers : evidence from atomic force microscopy and functional assay. Am J Pathol 163 (2003) 1193-1200
15. Arai T., Matsubayashi H., Sugi T., Kondo A., Shida M., Suzuki T., et al. Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine. Am J Reprod Immunol 50 (2003) 202-208
16. Lieby P., Soley A., Levallois H., Hugel B., Freyssinet J.M., Cerutti M., et al. The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity. Blood 97 (2001) 3820-3828
17. Tripodi A., Chantarangkul V., Clerici M., Negri B., Galli M., and Mannucci P.M. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol 115 (2001) 672-678
18. Cornall R.J., Goodnow C.C., and Cyster J.G. The regulation of self-reactive B cells. Curr Opin Immunol 7 (1995) 804-811
19. Koenig-Marrony S., Soulas P., Julien S., Knapp A.M., Garaud J.C., Martin T., et al. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory. J Immunol 166 (2001) 1463-1470
20. Julien S., Soulas P., Garaud J.C., Martin T., and Pasquali J.L. B cell positive selection by soluble sel-antigen. J Immunol 169 (2002) 4198-4204
21. Li H., Jiang Y., Cao H., Radic M., Prak E.L., and Weigert M. Regulation of anti-phosphatidylserine antibodies. Immunity 18 (2003) 185-192
22. Lieby P., Soley A., Knapp A.M., Cerutti M., Freyssinet J.M., Pasquali J.L., et al. Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals. Blood 102 (2003) 2459-2465
23. Lieby P., Poindron V., Roussi S., Klein C., Knapp A.M., Garaud J.C., et al. Pathogenic antiphospholipid antibody : an antigen-selected needle in a haystack. Blood 104 (2004) 1711-1715
24. Matthew C.C. B cell biology, apoptosis, and autoantibodies to phospholipids. Thromb Res 114 (2004) 307-319
25. Atsumi T., Khamashta M.A., Andujar C., Leandro M.J., Amengual P.R., Ames P.R., et al. Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J Rheumatol 25 (1998) 69-73
26. Pierangeli S.S., Colden-Stanfield M., Liu X., Barker J.H., Anderson G.L., and Harris E.N. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99 (1999) 1997-2002
27. Rand J.H., Wu X.X., Andree H.A., Lockwood C.J., Guller S., Scher J., et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 337 (1997) 154-160
28. Girardi G., Redecha P., and Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10 (2004) 1222-1226
29. Holers V.M., Girardi G., Mo L., Guthridge J.M., Molina H., Pierangeli S.S., et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195 (2002) 211-220
30. Girardi G., Berman J., Redecha P., Spruce L., Thurman J.M., Kraus D., et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112 (2003) 1644-1654